Related Experiment Video
Updated: Jun 25, 2026

Direct Microbial Identification using An Automated Microbial Identification System to Facilitate the EUCAST RAST Method Without Mass Spectrometry
Published on: May 24, 2024
Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to
Matilde Gracia1, Carolina Díaz, Pilar Coronel
1Department of Medical Microbiology and Antimicrobial Chemotherapy, Fundación Jiménez Díaz, 28040 Madrid, Spain.
Abstract:
The in vitro activity of penicillin, ampicillin, cefditoren, cefotaxime, erythromycin, clarithromycin, and levofloxacin against 763 clinical isolates of Streptococcus pyogenes was determined. Clinically significant isolates collected from November 2005 to December 2006 in the Czech Republic, Slovakia, Hungary, Poland, Romania, Estonia, Latvia, and Lithuania (the latter 3 analyzed as Baltic countries) were studied. No resistance to beta-lactams and levofloxacin was found. The rate of erythromycin resistance in S. pyogenes varied among countries, being low (<10%) in Romania and Baltic countries, intermediate (10-20%) in Poland and Czech Republic, and high (>25%) in Hungary and Slovakia. The predominant (75.0%) erythromycin-resistant phenotype among S. pyogenes isolates was MLS(B). The identification of the prevalence of erythromycin resistance mechanism could have impact on the choice of empiric antibiotic therapy for the clinicians in such countries.
Insights
Erythromycin resistance in Streptococcus pyogenes varies across Central and Eastern Europe, with Hungary and Slovakia showing high rates. No resistance was observed for beta-lactams or levofloxacin, aiding antibiotic choice.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Streptococcus pyogenes is a significant human pathogen.
- Antibiotic resistance in S. pyogenes impacts treatment efficacy.
- Understanding regional resistance patterns is crucial for public health.
Purpose of the Study:
- To determine the in vitro antibiotic susceptibility of Streptococcus pyogenes clinical isolates.
- To assess the prevalence of resistance to key antibiotics across several European countries.
- To identify erythromycin resistance mechanisms in S. pyogenes.
Main Methods:
- In vitro antimicrobial susceptibility testing was performed.
- Seventy-six bacterial isolates of Streptococcus pyogenes were analyzed.
- Isolates were collected from November 2005 to December 2006.
Main Results:
- No resistance to penicillin, ampicillin, cefditoren, cefotaxime, or levofloxacin was detected.
- Erythromycin resistance rates varied significantly by country, from <10% to >25%.
- The MLS(B) phenotype was the predominant mechanism (75.0%) in erythromycin-resistant isolates.
Conclusions:
- Beta-lactams and levofloxacin remain effective against S. pyogenes in the studied region.
- High erythromycin resistance rates in certain countries necessitate careful consideration for empiric therapy.
- Monitoring resistance patterns is essential for guiding clinical decisions and public health strategies.
Related Concept Videos
Antimicrobial Effectiveness
Urine Studies II: Urine Culture and Sensitivity Test
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Streptococcal Pharyngitis